AKAfroditi Kanellopoulou

Afroditi Kanellopoulou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Afroditi Kanellopoulou has a total of 29 co-authors. Here are the top co-authors by number of shared publications:

  • Rachel Richardson

    Methods Support Unit, Cochrane, London, UK

    2 shared publications
  • Alicja Wolk

    Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet , Stockholm

    1 shared publication
  • Amanda I Phipps

    Public Health Sciences Division, Fred Hutchinson Cancer Center , Seattle, WA

    1 shared publication
  • Andrew T Chan

    Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School , Boston, MA

    1 shared publication
  • Anna H Wu

    University of Southern California Department of Population and Public Health Sciences, Keck School of Medicine Los Angeles, CA

    1 shared publication
  • Athina Tzamouranou

    Pharmacy Department, Aristotle University of Thessaloniki, Thessaloniki, Greece

    1 shared publication

Latest Publications

  • Open Access

    Investigating the association between anthropometry and colorectal cancer survival: a two-sample Mendelian randomization analysis

    by Afroditi Kanellopoulou, Emmanouil Bouras, Andrew T Chan, Loïc Le Marchand, Alicja Wolk, Anna H Wu, Marc J Gunter, Katharina Nimptsch, Philip Haycock, Sarah J Lewis, et al.

    Background: Observational epidemiologic studies on the association of anthropometric traits and colorectal cancer (CRC) survival provide inconsistent results, and potential limitations prohibit the investigation of causality. We examined the associations between seven genetically predicted anthropometric traits [height, body mass index (BMI), waist circumference (WC), hip circumference (HC), waist–hip circumference ratio, birth weight and body fat percentage] and CRC-specific mortality among CRC cases using two-sample Mendelian randomization (MR). Methods: Analyses were performed using 16 964 CRC cases, out of which 4010 died due to their disease, from the Genetics and Epidemiology of Colorectal Cancer Consortium and Colon Cancer Family Registry. We further conducted stratified analyses by anatomical site and stage. We applied the inverse variance weighted approach, and sensitivity analyses were conducted to assess the impact of potential violations of MR assumptions and adjust for collider bias. Results: One standard deviation (SD 13.4 cm) higher genetically predicted levels of WC were associated with worse CRC survival [hazard ratio (HR); 1.22, 95% confidence interval (CI); 1.02–1.47]. Positive associations were further observed for a SD higher genetically predicted BMI (SD; 4.8 kg/m2, HR; 1.5, 95% CI; 1.15–1.95) and HC (SD; 9.2 cm, HR; 1.32, 95% CI; 1.02–1.73) and CRC-specific mortality in cases of stages II/III. The latter associations were generally robust to sensitivity analyses. Positive but imprecisely estimated associations were found for most other anthropometric traits. Conclusions: Despite the limitations of cancer survival research, our findings support that CRC cases should avoid obesity. Further research should inform the development of recommendations targeting overweight/obesity management during cancer surveillance.


  • Incorporating non-randomized evidence in cochrane intervention reviews: a scoping review

    by Emma Axon, Afroditi Kanellopoulou, Sofia Tsokani, Nuala Livingstone, Jennifer Hilgart, Rachel Richardson


  • Open Access

    Common statistical errors in systematic reviews: A tutorial

    by Afroditi Kanellopoulou, Kerry Dwan, Rachel Richardson

    The aim of this article is to present the most common statistical errors in meta‐analyses included in systematic reviews; these are confusing standard deviation and standard error, using heterogeneity estimators for choosing between a common‐effect and random‐effects model, improper handling of multiarm trials, and unnecessary and misinterpreted subgroup analyses. We introduce some useful terminology and explain what authors can do to avoid these errors and how peer reviewers can spot them. We have also developed a micro‐learning module to provide practical hands‐on tutorial.


  • Open Access

    Difference on Glucose Profile From Continuous Glucose Monitoring in People With Prediabetes vs. Normoglycemic Individuals: A Matched-Pair Analysis

    by Evangelos C. Rizos, Afroditi Kanellopoulou, Panagiotis Filis, Georgios Markozannes, Konstantinos Chaliasos, Evangelia E. Ntzani, Athina Tzamouranou, Nikolaos Tentolouris, Konstantinos K. Tsilidis

    Introduction: Comprehensive characteristics of the glycemic profile for prediabetes derived by continuous glucose monitoring (CGM) are unknown. We evaluate the difference of CGM profiles between individuals with prediabetes and normoglycemic individuals, including the response to oral glucose tolerance test (OGTT). Methods: Individuals with prediabetes matched for age, sex, and BMI with normoglycemic individuals were instructed to use professional CGM for 1 week. OGTT was performed on the second day. The primary outcomes were percentages of glucose readings time below range (TBR): 250 mg/dL. Area under the curve (AUC) was calculated following the OGTT. Glucose variability was depicted by coefficient of variation (CV), SD, and mean amplitude of glucose excursion (MAGE). Wilcoxon sign-ranked test, McNemar mid P-test and linear regression models were employed. Results: In all, 36 participants (median age 51 years; median body mass index [BMI] = 26.4 kg/m2) formed 18 matched pairs. Statistically significant differences were observed for 24-hour time in range (TIR; median 98.5% vs. 99.9%, P = .013), time above range (TAR) >180 mg/dl (0.4% vs. 0%, P = .0062), and 24-hour mean interstitial glucose (113.8 vs. 108.8 mg/dL, P = .0038) between people with prediabetes compared to normoglycemic participants. Statistically significant differences favoring the normoglycemic group were found for glycemic variability indexes (median CV 15.2% vs. 11.9%, P = .0156; median MAGE 44.3 vs. 33.3 mg/dL, P = 0.0043). Following OGTT, the AUC was significantly lower in normoglycemic compared to the prediabetes group (median 18615.3 vs. 16370.0, P = .0347 for total and 4666.5 vs. 2792.7, P = .0429 for incremental 2-hour post OGTT). Conclusion: Individuals with prediabetes have different glucose profiles compared to normoglycemic individuals. CGM might be helpful in individuals with borderline glucose values for a more accurate reclassification.